Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
AGN [NYSE]
Allergan Inc.
IndexS&P 500 P/E39.40 EPS (ttm)4.37 Insider Own0.10% Shs Outstand296.91M Perf Week-0.15%
Market Cap51.12B Forward P/E21.27 EPS next Y8.10 Insider Trans0.68% Shs Float295.26M Perf Month1.74%
Income1.32B PEG2.32 EPS next Q1.47 Inst Own91.70% Short Float1.08% Perf Quarter3.85%
Sales6.75B P/S7.57 EPS this Y17.60% Inst Trans10.86% Short Ratio1.08 Perf Half Y50.81%
Book/sh22.80 P/B7.55 EPS next Y39.80% ROA11.90% Target Price200.14 Perf Year89.51%
Cash/sh12.51 P/C13.76 EPS next 5Y17.00% ROE19.40% 52W Range86.84 - 174.49 Perf YTD55.11%
Dividend0.20 P/FCF- EPS past 5Y17.90% ROI15.70% 52W High-1.33% Beta0.76
Dividend %0.12% Quick Ratio3.80 Sales past 5Y7.40% Gross Margin87.80% 52W Low98.26% ATR2.93
Employees11700 Current Ratio4.10 Sales Q/Q16.70% Oper. Margin30.70% RSI (14)57.78 Volatility1.18% 1.65%
OptionableYes Debt/Eq0.32 EPS Q/Q17.10% Profit Margin18.60% Rel Volume0.49 Prev Close170.90
ShortableYes LT Debt/Eq0.31 EarningsJul 21 BMO Payout4.60% Avg Volume2.95M Price172.17
Recom2.00 SMA202.36% SMA503.70% SMA20032.47% Volume1,454,300 Change0.74%
22-Jul-14Upgrade UBS Neutral → Buy $180 → $200
28-Apr-14Downgrade Stifel Buy → Hold
22-Apr-14Downgrade Argus Buy → Hold
07-Mar-14Reiterated Barclays Equal Weight $95 → $130
07-Feb-14Reiterated Argus Buy $110 → $130
08-Jan-14Reiterated Argus Buy $110 → $125
07-Jan-14Initiated RBC Capital Mkts Outperform $131
20-Dec-13Reiterated UBS Buy $100 → $116
20-Dec-13Reiterated BMO Capital Markets Outperform $112 → $117
31-Oct-13Reiterated Argus Buy $118 → $110
25-Jun-13Reiterated Canaccord Genuity Hold $111 → $98
24-Jun-13Downgrade Deutsche Bank Buy → Hold
02-May-13Reiterated RBC Capital Mkts Outperform $123 → $119
06-Feb-13Reiterated Stifel Nicolaus Buy $110 → $118
06-Feb-13Reiterated Canaccord Genuity Hold $102 → $111
22-Jan-13Reiterated Canaccord Genuity Hold $101 → $102
19-Sep-12Initiated Canaccord Genuity Hold $101
30-Mar-12Reiterated RBC Capital Mkts Outperform $93 → $106
29-Mar-12Reiterated UBS Buy $100 → $107
29-Mar-12Reiterated Stifel Nicolaus Buy $90 → $110
30-Jul-14 05:19PM  [$$] Allergan Defends Bylaws Amid Effort to Ward Off Valeant at The Wall Street Journal
10:29AM  Today's Momo Momentum Stock To Watch: Allergan (AGN) at TheStreet
29-Jul-14 09:38AM  Pfizer Beats on Q2 Earnings, Revs Despite Generic Pressures Zacks
28-Jul-14 05:30PM  Novartis Division Gets European Approval for Simbrinza Zacks
25-Jul-14 12:16PM  Allergan gets EU recommendation on new use of eye drug Reuters
08:46AM  Allergan gets EU recommendation on new use of eye drug Reuters
07:55AM  Allergan Announces OZURDEX┬« (dexamethasone 700 mcg intravitreal implant in applicator) Receives European Positive Opinion for the Treatment of Diabetic Macular Edema Business Wire
24-Jul-14 12:04PM  Botox Makers Bosses Put Money Where Their Mouths Are at New York Times
12:04PM  Allergans Bosses Put Money on Where Their Mouths Are at New York Times
10:35AM  If Valeant Buys Allergan, Many Docs Will Shift Business, a Survey Finds at The Wall Street Journal
10:17AM  Wall Street Junk Euphoria Backs Ackmans Allergan Dreams at Bloomberg
09:49AM  If Valeant Buys Allergan, Many Docs Will Shift Business, a Survey Finds at The Wall Street Journal
08:10AM  Valeant files official complaint about Allergan with Canadian regulator at MarketWatch
08:00AM  Valeant Pharmaceuticals Files An Official Complaint With The Autorite Des Marches Financiers About Allergan's False And Misleading Statements PR Newswire
08:00AM  Valeant Pharmaceuticals Files An Official Complaint With The Autorite Des Marches Financiers About Allergan's False And Misleading Statements CNW Group
06:58AM  Is Allergan (AGN) Stock a Solid Choice Right Now? Zacks
06:54AM  GlaxoSmithKline Slumps: GSK Falls 5.9% in Session Zacks
12:01AM  Republican lawmaker to grill U.S. SEC over Ackman tactics Reuters
23-Jul-14 06:10PM  Correction: Blog points out Valeant's diverse portfolio is key to its success at MarketWatch
03:02PM  Ominous Signs For Valeant In The Allergan Q2 Earnings Call at Seeking Alpha
02:53PM  Ackman's clients shrug off Herbalife embarrassment at CNBC
09:02AM  ALLERGAN INC Files SEC form 8-K, Other Events EDGAR Online
06:26AM  [$$] Allergan Leaves Investors Smiling at Barrons.com
22-Jul-14 08:50PM  Herbalife Bashing Brings Bill Ackman Behind Where He First Began at Bloomberg
08:03PM  Allergan employees have mixed emotions as layoffs loom at Los Angeles Times
04:33PM  BTIG: Valeant Must Sweeten Allergan Bid To More Than $200/Share Benzinga
03:30PM  Allergan, a Valeant Takeover Target, Plans 1,500 Job Cuts Zacks
02:11PM  Allergan: Waiting for a Deal at Barrons.com
01:26PM  [$$] Allergan to Cut 13% of Workforce at The Wall Street Journal
11:26AM  Allergan upgraded by UBS Briefing.com
11:16AM  [video] Upgrades for Allergan and Chipotle, Amazon Downgraded at TheStreet
09:37AM  Allergan Reiterates Plan to Preempt Valeant Offer at TheStreet
09:33AM  UPDATE: UBS Securities Upgrades Allergan On Conference Call Takeaways Benzinga
09:17AM  Company News for July 22, 2014 Zacks
09:12AM  Will This Analyst Upgrade Help Allergan (AGN) Stock Today? at TheStreet
08:55AM  Allergan price target raised to $230 from $202 at BMO Capital at theflyonthewall.com
08:35AM  Top Analyst Upgrades and Downgrades: Allergan, Amazon, Chipotle, Netflix, QIWI, Sarepta and More at 24/7 Wall St.
07:27AM  Allergan stand alone value now above Valeant offer, says Bernstein at theflyonthewall.com
03:00AM  Allergan to slash workforce by 1,500 at Los Angeles Times
12:56AM  [$$] Allergan to Lay Off 13% of Workforce, Cut Drug Research at The Wall Street Journal
21-Jul-14 08:40PM  [$$] Allergan to Lay Off 13% of Workforce, Cut Drug Research at The Wall Street Journal
06:30PM  Allergan EPS Growth, Job Cuts Counter Valeant Investor's Business Daily
06:08PM  Dealpolitik: Valeant Calls Foul on Allergan's Withering Attacks at The Wall Street Journal
05:14PM  Allergan to cut 1,500 employees in restructuring AP
05:04PM  [$$] Allergan to Cut 13% of Workforce at The Wall Street Journal
04:37PM  [$$] Allergan to Cut 13% of Workforce at The Wall Street Journal
04:35PM  [video] Markets End Lower on Geopolitical Worries, Q2 Results Due at TheStreet
04:25PM  [video] What to Expect from Ackmans Herbalife Presentation at Bloomberg
04:22PM  On The Fly: Closing Wrap at theflyonthewall.com
04:21PM  Greenberg: Allergan's Dilemma at TheStreet
04:01PM  Under-Promising and Over-Delivering: Why Allergan Is a Buy at Wall St. Cheat Sheet
03:59PM  Most of Allergan's 1,500 job cuts will be in Southern California at Los Angeles Times
03:46PM  [$$] Allergan to Cut 13% of Workforce at The Wall Street Journal
03:35PM  Allergan to cut 13 percent of jobs in fight against Valeant Reuters
03:28PM  How Much Will Those Allergan Cost Cuts Really Help? Read Here at The Wall Street Journal
03:14PM  [$$] Allergan to Cut 13% of Workforce at The Wall Street Journal
02:54PM  Botox Maker Plans Deep Job Cuts During Takeover Fight at BusinessWeek
02:21PM  Allergan: Take That Valeant Pharmaceuticals! at Barrons.com
02:09PM  Allergan Stock Earnings: Good Enough to Fight off Valeant? at Motley Fool
01:53PM  Blog points out Valeant's diverse portfolio is key to its success at MarketWatch
01:45PM  Allergan to cut 1,500 employees in restructuring AP
01:11PM  Ackman says Valeant-Allergan deal looks closer-CNBC Reuters
01:07PM  Regional banks slip after BB&T setback at Financial Times
12:37PM  Video: Allergan Earnings, Job Cuts Counter Valeant at Investor's Business Daily
12:37PM  Video: Allergan Earnings Growth, Job Cuts Counter Valeant at Investor's Business Daily
12:37PM  Allergan Earnings Growth, Job Cuts Counter Valeant at Investor's Business Daily
12:35PM  [video] Allergan Plays Defense Against Valeant at Bloomberg
12:32PM  Botox maker Allergan to cut 1,500 jobs at USA TODAY
12:30PM  [video] Big pharma battle escalates at CNBC
12:24PM  Midday movers: Allergan, BB&T, McDonald's & More at CNBC
12:10PM  On The Fly: Midday Wrap at theflyonthewall.com
12:01PM  Allergan to cut 1,500 jobs as it battles Valeant at Los Angeles Times
11:59AM  [video] U.S. Charges Russia With Hiding Evidence in MH17 Downing at MarketWatch
11:48AM  Allergan's Best Defense: Delay, Delay, Delay at The Wall Street Journal
11:35AM  [video] U.S.Charges Russia of Hiding Evidence in MH17 Downing at MarketWatch
11:35AM  Allergan results turn up the heat on Valeant at MarketWatch
11:34AM  [$$] Large Allergan Investor Sells Most of Stake at The Wall Street Journal
11:29AM  Allergan Earnings Growth, Job Cuts Counter Valeant at Investor's Business Daily
11:16AM  Allergan Beats on Q2 Earnings, Ups View & Plans 13% Job Cut Zacks
11:15AM  Allergan's Best Defense: Delay, Delay, Delay at The Wall Street Journal
11:10AM  Allergan to cut 13 percent of jobs in fight against Valeant Reuters
11:04AM  EMC, GoPro jump; BB&T, DaVita, Six Flags sink at MarketWatch
10:41AM  [$$] Large Allergan Investor Sells Most of Stake at The Wall Street Journal
10:23AM  Allergan to cut 1,500 jobs as it fights Valeant takeover bid at Financial Times
10:11AM  [$$] Large Allergan Investor Sells Most of Stake at The Wall Street Journal
10:06AM  [$$] Allergan to Cut 13% of Work Force at The Wall Street Journal
09:58AM  ALLERGAN INC Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Financial Statements an EDGAR Online
09:48AM  Allergan to cut 1,500 employees in restructuring AP
09:45AM  Allergan Chops 1,500 Jobs to Fend Off Valeant at 24/7 Wall St.
09:44AM  [video] Faber Report: Allergan vs. Valeant at CNBC
09:43AM  [$$] Allergan to Cut 13% of Work Force at The Wall Street Journal
09:41AM  Allergan to cut about 1,500 jobs to evade Valeant takeover at Los Angeles Times
09:38AM  [$$] Large Allergan Investor Sells Most of Stake at The Wall Street Journal
09:17AM  Stock market live blog: Pulling back on Ukraine, Gaza worries; Allergan climbs at MarketWatch
09:14AM  [$$] Allergan to Cut 13% of Work Force at The Wall Street Journal
09:08AM  Mondays Top Biotech Stories: Allergan, Anacor, and Sinovac Biotech at Motley Fool
09:02AM  Allergan to cut 1,500 jobs as it fights Valeant bid Reuters
08:53AM  [video] Cramer's stocks to watch: AGN & VRX at CNBC
08:44AM  Allergan to cut 1,500 employees in restructuring AP
08:39AM  Valeant Complains To SEC About Allergan's War Of Words at Forbes
Allergan, Inc. operates as a multi-specialty health care company primarily in the United States, Europe, Latin America, and the Asia Pacific. The company discovers, develops, and commercializes pharmaceutical, biological, medical device, and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, urological, and other specialty markets. It operates in two segments, Specialty Pharmaceuticals and Medical Devices. The Specialty Pharmaceuticals segment produces a range of pharmaceutical products, including ophthalmic products for dry eye, glaucoma, inflammation, infection, allergy, and retinal disease; Botox for certain therapeutic and aesthetic indications; skin care products for acne, psoriasis, eyelash growth, and other prescription and physician-dispensed skin care products; and urologics products. The Medical Devices segment offers a range of medical devices, such as breast implants for augmentation, revision, and reconstructive surgery, as well as tissue expanders; and facial aesthetics products. The company sells its products to drug wholesalers, independent and chain drug stores, pharmacies, commercial optical chains, opticians, mass merchandisers, food stores, hospitals, group purchasing organizations, integrated direct hospital networks, ambulatory surgery centers, government purchasing agencies, and medical practitioners. It focuses on eye care professionals, neurologists, physiatrists, dermatologists, plastic and reconstructive surgeons, aesthetic specialty physicians, urologists, urogynecologists, and general practitioners. The company has collaboration agreements with Molecular Partners AG; Spectrum Pharmaceuticals, Inc.; and Serenity Pharmaceuticals, LLC. Allergan, Inc. was founded in 1948 and is headquartered in Irvine, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Sherman Scott DExecutive Vice President, HRApr 22Option Exercise75.5810,000755,80018,223Apr 23 07:25 PM
Sherman Scott DExecutive Vice President, HRApr 22Sale163.0010,0001,630,0008,223Apr 23 07:25 PM
Sherman Scott DExecutive Vice President, HRApr 21Option Exercise73.044,500328,68012,723Apr 23 07:25 PM
Sherman Scott DExecutive Vice President, HRApr 21Sale139.854,500629,3258,223Apr 23 07:25 PM
INGRAM DOUGLAS SPresidentFeb 21Sale125.701961,044Feb 25 05:49 PM
LAVIGNE LOUIS J JRDirectorFeb 21Sale125.795,400679,2440Feb 24 07:59 PM
Diradoorian Raymond HEVPGlobal Technical OperationsFeb 19Option Exercise58.5523,0001,346,65029,401Feb 21 04:56 PM
EDWARDS JEFFREY LEVP, Fin & Bus. Dev., CFOFeb 19Option Exercise40.1638,9001,562,22455,491Feb 21 04:59 PM
Diradoorian Raymond HEVPGlobal Technical OperationsFeb 19Sale126.6623,0002,913,1116,401Feb 21 04:56 PM
HUDSON DAWN EDirectorFeb 19Sale126.354,200530,68311,600Feb 21 05:14 PM
EDWARDS JEFFREY LEVP, Fin & Bus. Dev., CFOFeb 19Sale126.3938,9004,916,49316,591Feb 21 04:59 PM
Sherman Scott DExecutive Vice President, HRFeb 18Option Exercise75.585,000377,90013,220Feb 19 02:44 PM
Sherman Scott DExecutive Vice President, HRFeb 18Sale125.745,000628,7008,220Feb 19 02:44 PM
INGRAM DOUGLAS SPresidentFeb 14Option Exercise55.9884,0004,701,90085,058Feb 19 02:41 PM
Sherman Scott DExecutive Vice President, HRFeb 14Sale124.761708,220Feb 19 02:44 PM
INGRAM DOUGLAS SPresidentFeb 14Sale124.4084,00010,449,4321,058Feb 19 02:41 PM
PYOTT DAVID E IChairman of the Board and CEOFeb 12Option Exercise36.15252,0009,109,800417,000Feb 13 05:49 PM
BARLOW JAMES FSR. VP, Corp. Controller (PAO)Feb 12Option Exercise65.9223,8751,573,76930,754Feb 13 05:54 PM
PYOTT DAVID E IChairman of the Board and CEOFeb 12Sale123.12252,00031,025,560165,000Feb 13 05:49 PM
BARLOW JAMES FSR. VP, Corp. Controller (PAO)Feb 12Sale123.5223,8752,949,0416,879Feb 13 05:54 PM
Diradoorian Raymond HEVPGlobal Technical OperationsFeb 11Option Exercise55.9817,000951,57523,401Feb 13 05:56 PM
LAVIGNE LOUIS J JRDirectorFeb 11Option Exercise55.2054,6003,014,01924,123Feb 13 05:59 PM
Diradoorian Raymond HEVPGlobal Technical OperationsFeb 11Sale121.8217,0002,070,9576,401Feb 13 05:56 PM
LAVIGNE LOUIS J JRDirectorFeb 11Sale122.3954,6006,682,69612,723Feb 13 05:59 PM
Sherman Scott DExecutive Vice President, HRFeb 10Option Exercise75.585,000377,90013,325Feb 11 08:41 PM
Sherman Scott DExecutive Vice President, HRFeb 10Sale120.005,000600,0008,325Feb 11 08:41 PM
EDWARDS JEFFREY LEVP, Fin & Bus. Dev., CFOFeb 07Option Exercise64.47105,5006,801,585122,371Feb 11 08:37 PM
Sherman Scott DExecutive Vice President, HRFeb 07Option Exercise73.044,500328,68012,825Feb 11 08:41 PM
Sherman Scott DExecutive Vice President, HRFeb 07Sale118.554,500533,4848,325Feb 11 08:41 PM
EDWARDS JEFFREY LEVP, Fin & Bus. Dev., CFOFeb 07Sale117.74105,50012,421,04316,871Feb 11 08:37 PM
Whitcup Scott MExecutive VP, R&D, CSOJan 14Option Exercise55.9842,0002,350,95059,327Jan 15 06:24 PM
Whitcup Scott MExecutive VP, R&D, CSOJan 14Sale117.8042,0004,947,60017,327Jan 15 06:24 PM
Whitcup Scott MExecutive VP, R&D, CSOJan 08Option Exercise55.9842,0002,350,95059,327Jan 10 06:37 PM
Whitcup Scott MExecutive VP, R&D, CSOJan 08Sale113.8042,0004,779,60017,327Jan 10 06:37 PM
Gangolli Julian SCVP & Pres, North AmericaDec 27Option Exercise53.7152,5002,819,77545,547Dec 30 05:18 PM
Gangolli Julian SCVP & Pres, North AmericaDec 27Sale110.0552,5005,777,5508,047Dec 30 05:18 PM
Whitcup Scott MExecutive VP, R&D, CSODec 20Option Exercise36.1533,0001,192,95033,827Dec 20 07:41 PM
Whitcup Scott MExecutive VP, R&D, CSODec 20Option Exercise0.0033,000033,827Jan 06 06:27 PM
Whitcup Scott MExecutive VP, R&D, CSODec 20Sale108.8033,0003,590,40017,327Jan 06 06:27 PM
Whitcup Scott MExecutive VP, R&D, CSODec 20Sale108.8033,0003,590,40017,327Dec 20 07:41 PM
HUDSON DAWN EDirectorNov 27Sale97.463,000292,38215,800Dec 02 04:52 PM
Jones Trevor MDirectorOct 15Option Exercise51.721,00051,7159,142Oct 16 04:54 PM
Jones Trevor MDirectorOct 15Sale90.142,000180,2807,142Oct 16 04:54 PM
Jones Trevor MDirectorSep 16Option Exercise51.721,00051,71510,142Sep 17 07:38 PM
Jones Trevor MDirectorSep 16Sale89.782,000179,5608,142Sep 17 07:38 PM
Jones Trevor MDirectorAug 15Option Exercise51.721,00051,71511,142Aug 16 07:38 PM
Jones Trevor MDirectorAug 15Sale89.892,000179,7809,142Aug 16 07:38 PM
EDWARDS JEFFREY LEVP, Fin & Bus. Dev., CFOAug 06Option Exercise47.9269,2003,316,06056,871Aug 08 05:01 PM
EDWARDS JEFFREY LEVP, Fin & Bus. Dev., CFOAug 06Sale91.1769,2006,308,74616,871Aug 08 05:01 PM